Clinico-epidemiological study of vitiligo in a tertiary care hospital of Eastern India

Authors

  • Jayanta Kumar Barua Department of Dermatology School of Tropical Medicine, Kolkata
  • Kaushiki Hazra Department of Dermatology, School of Tropical Medicine, Kolkata
  • Prabal Samanta Department of Dermatology, School Of Tropical Medicine, Kolkata
  • Param Satsangi Department of Dermatology, School of Tropical Medicine, Kolkata
  • Tirtharaj Saha Department of Dermatology, School of Tropical Medicine, Kolkata
  • Professor Saswati Halder Department of Dermatology, School of Tropical Medicine, Kolkata

Keywords:

Vitiligo, acrofacial, triggering factor, autouimmune

Abstract

  Background  Vitiligo is a common acquired pigmentary disorder with a worldwide incidence of 0.2-2% whereas in India it is 0.5-2.5%.  Though having insignificant mortality, it causes heavy burden on the morbidity owing to its pycho-social impacts. Also, there is association with other autoimmune disorders like Type 1 diabetes Mellitus, thyroid disorder, pernicious anaemia, Inflammatory bowel disease, psoriasis, lichen planus, alopecia areata etc. There are several clinical variants like acrofacial, universalis, focal, segmental, mucosal etc. There are various treatment modalities both topical ( steroids, calcineurin inhibitors psoralens) as well as systemic like steroids, psoralens, cyclosporine and JAK inhibitors like Tofacitinib.   Methods This is a clinico-epidemiological study conducted over a period of 6 months. Study population comprised of 100 consecutive patients attending the OPD. Written consent was provided to the patients followed by history taking and clinical examination. Severely ill, pregnant patients and those unwilling to participate were excluded. Study variables included both epidemiological and clinical parameters like age, sex, occupation, morphological type, age of onset, associated autoimmune diseases etc.  Data collected was tabulated, analysed and compared with existing literature.   Results  Out of 100 patients enrolled in our study, majority (48%) belonged to the age of adolescents and young adults (11-30 yrs.), mean age being 28.4. 54% were females. Majority (45%) had access to primary education but not completing secondary exam. Most (35%) had onset in childhood (<12 yrs.), while majority had duration of disease between 1-10 yrs. (58%).   Only 3% had family history of vitiligo. Most of them (79%) had no obvious triggering factor while Half of the patients had stable disease for more than 1 year. 87% of the patients did not have any association with any other autoimmune disorders.  Generalised vitiligo (41%) was the most common subtype while only 1 patient had vitiligo universalis. 64% of the patients had received a combination of systemic and topical treatment before.   Conclusion  Our study provides an inight into the prevalence, socio-demographic factors and the various clinical parameters of vitiligo as well as their association with other autoimmune disorders. This study has also been compared with other studies conducted previously which shows the results of increased female preponderance, and generalised vitiligo being the most common subtype. In our study only 3% patients had positive family history which is less compared to other studies done previously.

Author Biographies

Jayanta Kumar Barua, Department of Dermatology School of Tropical Medicine, Kolkata

Associate Professor  

Kaushiki Hazra, Department of Dermatology, School of Tropical Medicine, Kolkata

Junior Resident  

Prabal Samanta, Department of Dermatology, School Of Tropical Medicine, Kolkata

Senior Resident

Param Satsangi, Department of Dermatology, School of Tropical Medicine, Kolkata

Junior Resident

Tirtharaj Saha, Department of Dermatology, School of Tropical Medicine, Kolkata

Junior Resident

Professor Saswati Halder, Department of Dermatology, School of Tropical Medicine, Kolkata

Head Of The Department

References

Khaitan BK, Kathuria S, Ramam M. A descriptive study to characterize segmental vitiligo. Indian J Dermatol Venereol Leprol. 2012;78:715-21.

Sarin RC, Kumar AJ. A clinical study of vitiligo. Indian J Dermatol Venereal Leprol. 1977;43:311-4.

Howitz J, Brodhagen H, Schwartz M, et al. prevalence of vitiligo. Arch Dermatol. 1977;113:47-52.

Koranne RV, Sehgal VN, Sachdev KG. Clinical profile of vitiligo in North India. Indian J Dermatol Venereal Leprol. 1986; 52:81-2.

Dutta AK, Mandal SB. A clinical study of 650 cases of vitiligo and their classification. Indian J Dermatol. 1969; 14:103-11.

Martis, Jacintha et al. A clinical study of vitiligo. Indian J Dermatol Venereol Leprol. 2002;68(2):92-3.

Taneja, Neha; Sreenivas, V.1; Sahni, Kanika; Gupta, Vishal; Ramam, M. Disease Stability in Segmental and Non-Segmental Vitiligo, Indian Dermatol Online J. 2022;13(1):60-3.

doi: 10.4103/idoj.IDOJ_154_21.

Downloads

Published

2023-03-05

How to Cite

1.
Jayanta Kumar Barua, Kaushiki Hazra, Prabal Samanta, Param Satsangi, Tirtharaj Saha, Professor Saswati Halder. Clinico-epidemiological study of vitiligo in a tertiary care hospital of Eastern India. J Pak Assoc Dermatol [Internet]. 2023Mar.5 [cited 2024Jun.17];33(1):37-42. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/2026

Issue

Section

Original Articles